-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Marker Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
- Marker Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $51K, a 64.1% decline year-over-year.
- Marker Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $246K, a 84.5% decline year-over-year.
- Marker Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $246K, a 84.5% decline from 2023.
- Marker Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.58M, a 70.4% decline from 2022.
- Marker Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.34M, a 10.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)